Related Experiment Video
Updated: Nov 12, 2025

10:09
Transtubular Endoscopic Posterolateral Decompression for L5-S1 Lumbar Lateral Disc Herniation
Published on: October 14, 2022
4.2K
CT-Guided Posterolateral Full-Endoscopic Ventral Decompression for Single-Level Cervical Spondylotic Myelopathy
Bing Ran1, Jun Yang1, Jun Wei1
1The First Affiliated Hospital of GanNan Medical College, GanZhou, China.
Pain Physician
|March 19, 2021
Summary
Posterolateral full-endoscopic ventral decompression (PLEVD) is a safe and effective minimally invasive technique for treating single-level cervical spondylotic myelopathy (CSM), showing significant improvements in patient outcomes and spinal canal diameter.
Area of Science:
- Neurosurgery
- Orthopedic Surgery
- Minimally Invasive Spine Procedures
Background:
- Cervical spondylotic myelopathy (CSM) is a degenerative condition affecting the spinal cord.
- Percutaneous full-endoscopic surgery has shown promise for other cervical spine conditions.
- Limited research exists on endoscopic approaches for CSM.
Purpose of the Study:
- To evaluate the safety, feasibility, and efficacy of posterolateral full-endoscopic ventral decompression (PLEVD).
- To assess CT-guided PLEVD in patients with single-level CSM.
- To observe neurological improvement and pain reduction post-procedure.
Main Methods:
- Prospective cohort study involving 21 patients with single-level CSM.
- CT-guided PLEVD performed via a posterolateral approach.
- Evaluation using Japanese Orthopaedic Association (JOA) scores, Visual Analog Scale (VAS), and maximum spinal canal diameter (MSCD) measurements.
Main Results:
- Significant reduction in limb pain (VAS scores) and improvement in neurological function (JOA scores).
- Nineteen out of 21 patients achieved good or excellent outcomes.
- Mean maximum spinal canal diameter increased significantly post-surgery.
Conclusions:
- CT-guided PLEVD is a safe and feasible surgical option for single-level CSM.
- The technique demonstrates efficacy in improving neurological function and pain.
- Further nonrandomized, preliminary clinical results support its use under appropriate indications.

